{{Rsnum
|rsid=11191580
|Gene=NT5C2
|Chromosome=10
|position=104906211
|Orientation=plus
|GMAF=0.1313
|Gene_s=NT5C2
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=135
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 13.3 | 85.8
| HCB | 9.6 | 39.7 | 50.7
| JPT | 7.1 | 40.7 | 52.2
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 1.8 | 98.2
| CHB | 9.6 | 39.7 | 50.7
| CHD | 9.2 | 41.3 | 49.5
| GIH | 5.9 | 38.6 | 55.4
| LWK | 0.0 | 0.0 | 0.0
| MEX | 7.0 | 28.1 | 64.9
| MKK | 0.0 | 5.8 | 94.2
| TSI | 0.0 | 22.5 | 77.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21926974
|Trait=None
|Title=Genome-wide association study identifies five new schizophrenia loci.
|RiskAllele=T
|Pval=3E-8
|OR=1.2000
|ORtxt=[1.13-1.26]
|OA=1
}}

{{PMID Auto
|PMID=22520855
|Title=Association study of a new schizophrenia susceptibility locus of 10q24.32-33 in a Han Chinese population.
}}

{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=2E-9
|OR=1.2300
|ORtxt=None
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23453885
  |Trait=Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
  |Title=Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
  |RiskAllele=
  |Pval=1E-8
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}